![Thomas Mccarthy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Mccarthy
Fundador en
Pathios Therapeutics Ltd.
.
Perfil
Thomas Mccarthy is the founder of Pathios Therapeutics Ltd. (2017, Executive Chairman), Grey Wolf Therapeutics Ltd. (2017, Chairman), and ThirtyFiveBio Ltd. (2021, Executive Chairman).
Current jobs include Chairman at Orbit Discovery Ltd. and Venture Partner at Brandon Capital Partners Pty Ltd. Former jobs include CEO, Director & Managing Director at Spinifex Pharmaceuticals Pty Ltd. (2006-2015) and Vice President-Drug Development at Starpharma Holdings Ltd. Education includes an undergraduate degree from Monash University (1989) and a doctorate from Monash University (1993).
Cargos activos de Thomas Mccarthy
| Empresas | Cargo | Inicio |
|---|---|---|
Orbit Discovery Ltd.
 Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Develops technology for discovery process and drug development | Presidente | - |
Grey Wolf Therapeutics Ltd.
 Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Fundador | 01/01/2017 |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Fundador | 01/01/2017 |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 01/01/2015 |
ThirtyFiveBio Ltd.
 ThirtyFiveBio Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for digestive system disorders | Fundador | 26/01/2021 |
Antiguos cargos conocidos de Thomas Mccarthy.
| Empresas | Cargo | Fin |
|---|---|---|
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Director Ejecutivo | - |
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | - |
Formación de Thomas Mccarthy.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
78
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Starpharma Holdings Ltd.
 Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Develops technology for discovery process and drug development | Health Technology |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops next generation immuno-oncology drugs | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
ThirtyFiveBio Ltd.
ThirtyFiveBio Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for digestive system disorders | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Mccarthy
